Parmax Pharma Ltd Share Price – BSE

Pharmaceuticals, Small Cap

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 8 June 2026.

Net Loss of Parmax Pharma reported to Rs 0.58 crore in the quarter ended March 2026 as against net loss of Rs 1.49 crore during the previous quarter ended March 2025. Sales declined 31.47% to Rs 3.31 crore in the quarter ended March 2026 as against Rs 4.83 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 4.16 crore in the year ended March 2026 as against net loss of Rs 2.09 crore during the previous year ended March 2025. Sales declined 57.06% to Rs 12.11 crore in the year ended March 2026 as against Rs 28.20 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be held on 30 May 2026. The meeting will now be held on 2 June 2026.

Parmax Pharma has revised the meeting of the Board of Directors which was scheduled to be held on 30 May 2026. The meeting will now be held on 2 June 2026.